(2R,3R,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl Benzoate
Sofosibuvir Dicoupled Impurity is listed by Simson Pharma as a impurity standards for laboratory research, analytical development and quality-control workflows.
Suitability is method- and purpose-specific. Before use, verify the product name, catalogue number, chemical identifiers, storage requirements and the information reported in the current product or batch documentation. Your laboratory remains responsible for method qualification or validation.
Sofosibuvir Dicoupled Impurity for method validation Sofosibuvir Dicoupled Impurity reference standard Sofosibuvir Dicoupled Impurity for ANDA filing Sofosibuvir Dicoupled Impurity for forced degradation studies Sofosibuvir Dicoupled Impurity identification standard Sofosibuvir Dicoupled Impurity for DMF filing Sofosibuvir Dicoupled Impurity HPLC standard Sofosibuvir Dicoupled Impurity supplier Sofosibuvir Dicoupled Impurity manufacturer Sofosibuvir Dicoupled Impurity distributor
